Picodya was proud to participate in the Investival Showcase 2025, one of Europe’s leading healthcare investment conferences, held last week in London.
Tzvika Barkai, Picodya’s Co-Founder and CEO, was invited as a featured speaker to present the company’s vision for democratizing diagnostics through its Pico-Tech platform. Joining him at the conference was Opher Shapira, Picodya’s Chairman of the Board, underscoring the company’s strong leadership presence as it engages with global investors and industry partners.
During his talk, Mr. Barkai shared insights from Picodya’s journey, from its founding in Kibbutz Hatzerim, the birthplace of global irrigation pioneer Netafim, to developing a hybrid molecular–immunoassay platform that enables decentralized, real-time diagnostics at unprecedented scale and efficiency.
“Investival brings together the investors and innovators shaping the future of healthcare. It was a privilege to showcase how Pico-Tech is removing barriers in diagnostics and unlocking new possibilities for patient care worldwide.” – Tzvika Barkai
The conference gathered top investors, industry leaders, and emerging growth companies for a full day of presentations and discussions. Picodya’s participation highlights the company’s growing visibility in the global healthcare and medtech landscape and its momentum as it advances its mission to make diagnostics faster, more efficient, and more accessible.
